Provided by Tiger Fintech (Singapore) Pte. Ltd.

Sarepta Therapeutics

62.78
+0.38000.61%
Post-market: 64.011.23+1.96%19:49 EDT
Volume:1.36M
Turnover:85.55M
Market Cap:6.17B
PE:26.85
High:64.00
Open:62.45
Low:60.53
Close:62.40
Loading ...
Nov 03, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 15, 2021

Major Issues Report

8-K - Current report
Sep 27, 2021

Major Issues Report

8-K - Current report
Aug 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Aug 04, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 03, 2021

Major Issues Report

8-K - Current report
May 18, 2021

Major Issues Report

8-K - Current report
May 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 03, 2021

Major Issues Report

8-K - Current report
Mar 01, 2021

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 16, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 10, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 08, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 01, 2021

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Jan 11, 2021

Major Issues Report

8-K - Current report
Jan 07, 2021

Major Issues Report

8-K - Current report
Dec 14, 2020

Major Issues Report

8-K - Current report
Nov 05, 2020

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]